Myocardial levels of calcium, glycogen and triglycerides in ethanol-fed turkey poults treated with allopurinol

Czarnecki, Caroline M.; Olivero, Dennis K.; McVey, Alistair S.; Pessin, Mark F.

doi:10.1016/0742-8413(87)90185-x

Cited by 2 publications

(1 citation statement)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We downloaded the PD sample's data sets from the Gene Expression Omnibus (GEO) database then screened three sets of serum expression pro le data sets (GSE6613 [14,15], GSE57475[16], GSE99039 [17]) and three sets of substantia nigra expression pro le datasets(GSE7621[18], GSE20141 [19] ,GSE49036 [20]), one set of brain tissue data that matching with gene expression and miRNA expression(GSE110716 [21], GSE110717 [21]), and two sets of serum sample's methylation data sets (GSE111629 [22,23], GSE72774 [24,23]), each data statistics are showed as(Table 1). We download these standardized data sets on 2019-03-01.…”

Section: Data Collection and Processingmentioning

confidence: 99%

Application of serum SNCA gene in the diagnosis of Parkinson’s disease

Quan

Wang

et al. 2021

Preprint

View full text Add to dashboard Cite

Background: SNCA plays an important role in the development of Parkinson's disease. However, the mechanism in PD is still unclear. We integrate multi-omics data for systematic analysis to explore the potential mechanism and therapeutic target of SNCA in PD.Materials and methods: We download the gene expression, miRNA expression, and methylation data sets from GEO. After integration and standardization, analyze the diagnostic value and potential function of SNCA. Furthermore, according to the expression of SNCA, the important role of the genetic and epigenetic mechanism of SNCA co-expression in PD was analyzed by RNA-Seq, miRNA-Seq, and methylation data.Results: Six expression profiling data sets showed that SNCA is lowly expressed in PD and could be used as a potential PD marker. SNCA co-expressed genes in serum and substantia nigra samples have significant differences. The lncRNAs which most relevant to SNCA expression are related to a variety of tumors and nerve-related diseases meanwhile the miRNA which most relevant to SNCA expression is related to multiple neurodegenerative disease pathways. There are multiple CpG methylation sites in the SNCA promoter region, of which cg15133208 is significantly hypomethylated in PD.Conclusion: This study proposes low expression of SNCA as a diagnostic biomarker for PD, explores the unique genome and apparent landscape associated with expression of SNCA, provides ideas for a better understanding of the molecular basis of PD, and serves as a diagnostic biomarker for expression of SNCA or as a potential therapeutic target for PD patients which provides more direct evidence.

show abstract